DelveInsight Business Research, LLP: Myelodysplastic Syndrome Market to Climb Swiftly at a 13.2% CAGR During the Study Period [2018-2030], Evaluates DelveInsight
LAS VEGAS, March 8, 2022 /PRNewswire/ -- There has been a mediocre success with the approval of novel agents in Myelodysplastic Syndrome (MDS), where the patients had to wait for more than 13